Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page
- Check3 days agoChange DetectedRevision v3.6.2 was added. The previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now indicates no longer looking for participants and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label formatting is adjusted and the site revision is updated to v3.6.0.SummaryDifference0.5%

- Check24 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. No direct content changes to the study page are shown.SummaryDifference0.1%

- Check46 days agoChange DetectedA new site revision label (v3.5.4) has been added, replacing the previous revision (v3.5.3). This indicates a platform update rather than a modification to the study details.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now shows an updated site revision identifier (moving from v3.5.2 to v3.5.3), indicating a platform/version update without altering the study record content.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.